- Breast cancer
- Inflammatory breast cancer
- Invasive breast cancer
- Invasive ductal carcinoma
- Invasive lobular carcinoma
- Local tumor recurrence
- Male breast cancer
- Triple negative breast cancer
- Triple positive breast cancer
Eleanor P. Taranto, MD
Medical Oncology
Accepting new patients
Sees patients age 18 and up
Abramson Cancer Center Perelman 3rd Floor West
Penn Medicine Provider
About me
- Assistant Professor of Medicine (Hematology-Oncology) at the Hospital of the University of Pennsylvania
I am a medical oncologist specializing in breast cancer. I provide compassionate care tailored to each patient’s unique journey. I take a collaborative approach, guiding patients through treatment with empathy and clarity. I help connect patients to innovative clinical trials, offering access to emerging therapies while advancing cancer research. It is a privilege to support patients throughout their course of treatment at Penn Medicine.
My education and training
- Medical School: University of Chicago
- Residency: Brigham and Women's Hospital - Massachusetts General Hospital
- Fellowship: Hospital of the University of Pennsylvania
Spoken languages
English
English
Insurance accepted
Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.
- Aetna Advantra Cares D-SNP
- Aetna Advantra Credit Value
- Aetna Advantra Eagle HMO
- Aetna Advantra Eagle POS
- Aetna Advantra Premier Plus PPO
- Aetna Advantra Value
- Aetna Advantra Value Plus
- Aetna APCN Plus (Multi-Tier)
- Aetna Better Health Kids (CHIP) - DH Only
- Aetna Flexible Five
- Aetna Freedom Core
- Aetna Gold
- Aetna HMO
- Aetna Philly Prime
- Aetna POS
- Aetna PPO APCN
- Aetna Premier
- Aetna Premier Plus
- Aetna Savings Plus
- Aetna Signature Administrators
- Aetna Student Health Plan PPO
- Aetna Upfront Advantage
- First Health HMO
- First Health POS
- First Health PPO
- Meritain - Aramark (Other)
- Meritain - Aramark (Pennsylvania Premier Medical Plan)
- Americhealth Caritas of PA VIP - LGH Only
- Amerihealth Caritas (Transplant patients only)
- Amerihealth Caritas of PA - LGH Only
- Centivo EPO
- Cigna Healthcare EPO
- Cigna Healthcare HMO
- Cigna Healthcare POS
- Cigna Healthcare PPO
- Claim Watcher (Homestead/ INDECs) Open Access
- Clover Health Choice
- Clover Health Choice Value PPO
- Clover Health Classic HMO
- Clover Health Value
Locations
Penn Medicine hospital privileges
- Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
Qualifications and experience
- Internal Medicine, 2022
- Alpha Omega Alpha Honor Society, National
- American College of Physicians, National
- American Medical Association, National
- American Society of Clinical Oncology, National
- American Society of Hematology, National
- Society for General Internal Medicine, National
Treatments and conditions
Research
Publications
E. P. Taranto, W. Fawn, C. Desirae, E. Walinsky, S. Deluca, L. Bayne, E. P. Wileyto, A. Shirali, C. J. Robbins, Y. Abdou, J. Anampa, M. Balic, J. V. Canzoniero, N. C. Chen, F. Howard, L. Huppert, A. Kahn, C. Mainor, J. Mouabbi, V. Nair, T.Degeer, J. Weidler, T. McNicholas, C. Serway, J. Reischl, M. Bates, R. Monroe, D. L. Rimm, A. DeMichele Quantifyher (trial in progress): quantitative immunofluorescence and/or messenger rna to measure her2 expression in patients with metastatic breast cancer treated with trastuzumab deruxtecan (tbcrc066) , Clin Cancer Res , 32(4_Supplement): 2026,PS4-03-12
A. DeMichele, L. Bayne, E. Walinsky, L. Berry, S. Deluca, C. G. Smith, A. Chevalier, B. Ambasager, P. Sanchez, J. Heaven, E. Chislock, , T. Pan, J. Graves, G. Belka, J. Wang, E. Taranto, A. Nayak, M. Feldman, A. Clark, L. Chodosh 5-year outcomes and ctdna findings in the clever trial targeting disseminated dormant tumor cells , Clin Cancer Res, 32(4_Supplement): 2026,PD5-02
Taranto E, DeMichele A Evaluating the clinical utility of ctDNA testing to identify molecular cancer progression – lessons from SERENA-6 , NPJ Breast Cancer, 12(1): 2026,18
Taranto E, Seewald NJ, Bayne LJ, Deluca S, Shih NC, Sanchez P, Nivar I, Ambasager B, Murray C, Chevalier A, Smith CG, Makhlin I, Rohn K, Goodspeed BL, Savage J, Wileyto P, Wang J, Belka G, Chislock E, Berry LR, Berry D, Nayak A, Feldman M, Clark AS, Chodosh LA, & DeMichele A. Circulating tumor DNA (ctDNA), dormant disseminated tumor cells (DTCs) and recurrence outcomes in breast cancer survivors on the SURMOUNT Study. , Clin Cancer Res, 31 (12_Supplement): 2025,PS9-03
Taranto E, Barta S, Bhansali R. Central Nervous System Relapse in T and NK Cell Lymphomas , Curr Hematol Malig Rep, 18(6): 2023,243-251.
Taranto E, Hwang WT, Alfaro M, Surapaneni AS, Gill SK, Feldman T, Randall MP, Spinner MA, Furqan F, Shah NN, Samara Y, Mei MG, Herrera AF, Moskowitz A, Shah GL, & Svoboda J. Engraftment Syndrome during Autologous Stem Cell Transplant in Hodgkin Lymphoma Patients Treated with Checkpoint Inhibitors: A Multicenter Retrospective analysis. , Blood, 142(Supplement 1): 2023,3603
Merryman R, Redd R, Taranto E, Ahmed G, Jeter E, McHugh K, Brown J, Crombie J, Davids M, Fisher D, Freedman A, Jacobsen E, Jacobson C, Kim A, LaCasce A, Lampson B, Ng S, Odejide O, Dahi P, Nieto Y, Joyce R, Chen Y, Herrera A, Armand P. Minimal residual disease in patients with diffuse large B-cell lymphoma undergoing autologous stem cell transplantation. , Blood Adv, 7(17): 2023,4748-4759.
Merryman R, Spilberg G, Mondello P, Redd R, Taranto E, Ahmed G, Jeter E, Chase M, Salles G, Zelenetz A, Brown J, Crombie J, Davids M, Fisher D, Freedman A, Jacobsen E, Jacobson C, Kim A, LaCasce A, Lampson B, Ng S, Odejide O, Armand P, Jacene H. Interim Positron Emission Tomography during Frontline Chemoimmunotherapy for Follicular Lymphoma , Hemasphere , 7(2): 2023,e826.
Taranto E, Redd R, Jeter E, McHugh K, Crombie JL, Fisher DC, Jacobsen E, Jacobson CA, Kim AI, Odejide OO, Dahi PB, Nieto Y, Joyce RM, Chen YB, Bonjoc KC, Chaudhry A, Herrera AF, Armand P, Merryman RW. Prognostic Value of Minimal Residual Disease among Patients with Classical Hodgkin Lymphoma Undergoing Autologous Stem Cell Transplantation , Leuk Lymphoma, 63(12): 2022,2912-2917.
Kline J, Heusinkveld L, Taranto E, Martin C, Tomasi A, Hsu I, Cho K, Khillan J, Murphy P & Pontejo S. Structural and functional analysis of Ccr1l1, a Rodentia-restricted eosinophil-selective chemokine receptor homologue. , J Biol Chem , 296: 2021,100373.